Hepatic fibrogenesis and hepatitis C

D C Rockey1

  • 1Liver Center and Department of Medicine and Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.

Seminars in Gastrointestinal Disease
|May 10, 2000
PubMed

Insights

Hepatitis C virus (HCV) infection causes liver fibrosis and cirrhosis, posing a significant clinical challenge. Understanding HCV fibrogenesis is critical for developing new interventions to treat liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Pathology

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease worldwide.
  • HCV infection frequently progresses to liver fibrosis, cirrhosis, and associated complications.
  • Understanding the mechanisms of liver fibrogenesis in HCV is crucial for clinical management.

Observation:

  • Inflammation and cellular injury are key drivers of fibrogenesis in HCV infection.
  • Fibrosis represents a significant pathological response to persistent HCV-induced liver damage.
  • Cirrhosis, a consequence of advanced fibrosis, leads to severe clinical sequelae.

Findings:

  • This review elucidates the fundamental pathological basis of the fibrogenic response to HCV injury.
  • It identifies critical cellular and molecular pathways involved in HCV-driven liver fibrosis.
  • Potential therapeutic targets for interrupting fibrogenesis are highlighted.

Implications:

  • A deeper understanding of HCV fibrogenesis can guide the development of novel antifibrotic therapies.
  • Targeting fibrogenic pathways may prevent or reverse liver damage in HCV patients.
  • This knowledge is vital for improving long-term outcomes and reducing the burden of HCV-related liver disease.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...